Determinants of Human Receptor Specificity of Influenza A Virus H2N2 Hemagglutinin
Exclusively Licensed
Invention type: Technology
/
Case number: #14302
The present invention provides, among other things, methods, reagents, and systems for the treatment, detection, analysis, and/or characterization of influenza infections.
Researchers
Rahul Raman
/
Xiaoying Koh
/
Karthik Viswanathan
/
Aarthi Chandrasekaran
/
Ram Sasisekharan
Departments: Department of Biological Engineering, School of Engineering
Technology Areas: Biotechnology: DNA & RNA Editing, Synthetic Biology / Diagnostics: Assays / Drug Discovery and Research Tools: Genomics & Proteomics / Therapeutics: Proteins & Antibodies, Small Molecules
Impact Areas: Healthy Living
-
influenza treatment and/or characterization, human-adapted ha polypeptides; vaccines
United States of America | Granted | 9,745,352 -
influenza treatment and/or characterization, human-adapted ha polypeptides; vaccines
United States of America | Granted | 8,802,110 -
human-adapted ha polypeptides, vaccines, and influenza treatment
Australia | Granted | 2,011,305,371
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.